Latest News On Polls

Latest KFF Health News Stories

The Confusing Fate of the Abortion Pill

Podcast

The legality and availability of the abortion pill mifepristone is in question after a federal judge in Texas canceled the FDA’s approval of the first drug used in the two-drug medication abortion regimen. A 5th Circuit Court of Appeals panel overruled that decision in part, saying the pill should remain available, but only under the onerous restrictions in place before 2016. Meanwhile, another federal judge in Washington state issued a ruling in a separate case that conflicts with the Texas decision, ordering the FDA not to roll back any of its restrictions on the drug. Victoria Knight of Axios, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more.

Ask Voters Directly, and Abortion Rights Wins Most Ballot Fights

KFF Health News Original

Anti-abortion candidates have fared well in recent elections. But decades of ballot initiatives — including a half-dozen measures considered after the Supreme Court overturned Roe v. Wade last June — show that when voters are asked directly, they usually side with preserving abortion rights.

As Workers Struggle With Pandemic’s Impact, Employers Expand Mental Health Benefits

KFF Health News Original

Many job-based health plans broadened their mental health and substance use coverage to make sure workers had the support they needed this year as pandemic stress lingered, the annual KFF survey finds. Also, the proportion of employers offering health insurance to their workers remained steady, and increases for premiums and out-of-pocket health expenses were moderate.